A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Dexfenfluramine
Bifeprunox
The therapeutic efficacy of Safinamide can be decreased when used in combination with Bifeprunox.
Dexfenfluramine
Tetrabenazine
The risk or severity of adverse effects can be increased when Safinamide is combined with Tetrabenazine.
Dexfenfluramine
Tapentadol
The risk or severity of adverse effects can be increased when Tapentadol is combined with Safinamide.
Dexfenfluramine
Pizotifen
Safinamide may increase the anticholinergic activities of Pizotifen.
Dexfenfluramine
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Safinamide.
Dexfenfluramine
Dexmethylphenidate
Safinamide may increase the hypertensive activities of Dexmethylphenidate.
Dexfenfluramine
Oxaprotiline
The risk or severity of adverse effects can be increased when Safinamide is combined with Oxaprotiline.
Dexfenfluramine
Aptazapine
The risk or severity of adverse effects can be increased when Safinamide is combined with Aptazapine.
Dexfenfluramine
Setiptiline
The risk or severity of adverse effects can be increased when Safinamide is combined with Setiptiline.
Dexfenfluramine
Esmirtazapine
The risk or severity of adverse effects can be increased when Safinamide is combined with Esmirtazapine.
Dexfenfluramine
Mianserin
The risk or severity of adverse effects can be increased when Safinamide is combined with Mianserin.
Dexfenfluramine
Lithium hydroxide
The risk or severity of serotonin syndrome can be increased when Safinamide is combined with Lithium hydroxide.
Dexfenfluramine
Lithium carbonate
The risk or severity of serotonin syndrome can be increased when Safinamide is combined with Lithium carbonate.
Dexfenfluramine
Lithium citrate
The risk or severity of serotonin syndrome can be increased when Safinamide is combined with Lithium citrate.
Dexfenfluramine
Levonordefrin
Safinamide may increase the hypertensive activities of Levonordefrin.
Dexfenfluramine
Isometheptene
Safinamide may increase the sympathomimetic activities of Isometheptene.
Dexfenfluramine
Betahistine
The metabolism of Betahistine can be decreased when combined with Safinamide.
Dexfenfluramine
Naxitamab
The risk or severity of hypertension can be increased when Safinamide is combined with Naxitamab.
Dexfenfluramine
Loxoprofen
The risk or severity of hypertension can be increased when Safinamide is combined with Loxoprofen.
Dexfenfluramine
Selpercatinib
The risk or severity of hypertension can be increased when Safinamide is combined with Selpercatinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3